Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

107.93
Delayed Data
As of 3:59pm ET
 +0.41 / +0.38%
Today’s Change
92.98
Today|||52-Week Range
136.40
-9.88%
Year-to-Date
Celgene Can't Expand Revlimid Approval into Non-Hodgkin Lymphoma Just Yet
5:14pm / TheStreet.com - Paid Partner Content
Celgene (CELG) Stock Is the 'Chart of the Day'
Jul 22 / TheStreet.com - Paid Partner Content
3 Top Biotech Stocks to Buy Now
1:07pm / MotleyFool.com - Paid Partner Content
Stock Market News for July 21, 2016
Jul 21 / Zacks.com - Paid Partner Content
Celgene (CELG) Q2 Earnings: Can the Stock Pull a Surprise?
12:03pm / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen
Jul 21 / Zacks.com - Paid Partner Content
I'm Bullish on Biotechs
11:58am / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug
Jul 20 / Zacks.com - Paid Partner Content
I Just Bought These 4 Fast-Growing Biotech Stocks
Jul 23 / MotleyFool.com - Paid Partner Content
Celgene (CELG), Jounce Strike Immunotherapy Collaboration
Jul 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close107.52
Today’s open107.44
Day’s range106.73 - 108.14
Volume3,424,515
Average volume (3 months)4,545,571
Market cap$83.3B
Dividend yield--
Data as of 3:59pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+21.04%
Earnings growth (next 5 years)+23.20%
Revenue growth (last year)+16.47%
P/E ratio52.5
Price/Sales11.10
Price/Book14.29

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.02+0.06%
LLYEli Lilly and Co+0.39+0.48%
AGNAllergan-1.13-0.45%
ABTAbbott Laboratories+0.24+0.56%
Data as of 4:03pm ET, 07/25/2016

Financials

Last reporting dateJuly 21, 2016
EPS forecast (this quarter)$1.39
Annual revenue (last year)$8.9B
Annual profit (last year)$1.6B
Net profit margin18.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts

Partner Offers

Search for Jobs